Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A d'Arminio Monforte

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Current Molecular Pharmacology|December 22, 2009
Immunological mechanisms of interleukin-2 (IL-2) treatment in HIV/AIDS diseaseC Tincati, A d'Arminio Monforte, G Marchetti
Journal of Hepatology|June 1, 1993
Foscarnet treatment of chronic hepatitis B in an HIV-positive patientS Antinori, R Esposito, A d'Arminio Monforte, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 1999
Prevalence of transfusion-transmitted virus among human immunodeficiency virus-infected subjects in northern ItalyA Lobbiani, L Sciariada, R Morales, et al.
HIV Medicine|July 2, 2008
Indicator disease-guided testing for HIV--the next step for Europe?B Gazzard, N Clumeck, A d'Arminio Monforte, et al.
Gastroenterology|October 1, 1982
Serum immunoglobulins in acute hepatitisF Caredda, A D'Arminio Monforte, E Rossi, et al.
Giornale Italiano Di Chemioterapia|January 1, 1991
[Opportunistic infections and tumors in AIDS]A Lazzarin, A Danise, A D'Arminio-Monforte, et al.
The Journal of Infectious Diseases|February 1, 1984
An outbreak of delta agent among a group of drug addicts and their close contactsF Caredda, E Rossi, A d'Arminio Monforte, et al.
Rays|January 1, 1994
Opportunistic infections of central nervous system in immunocompromised patientsM Moroni, C Gervasoni, P Coppin, et al.
Antiviral Therapy|May 7, 2003
Anti-HIV-1 intermittent drug intensification in HIV-1-infected patients naive for antiretroviralsS Rusconi, B Argenteri, M Galli, et al.
Lancet (London, England)|July 4, 1981
Non-A, non-B hepatitis in MilanF Caredda, A d'Arminio Monforte, E Rossi, et al.
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Current Molecular Pharmacology|December 22, 2009
Immunological mechanisms of interleukin-2 (IL-2) treatment in HIV/AIDS diseaseC Tincati, A d'Arminio Monforte, G Marchetti
Journal of Hepatology|June 1, 1993
Foscarnet treatment of chronic hepatitis B in an HIV-positive patientS Antinori, R Esposito, A d'Arminio Monforte, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 1999
Prevalence of transfusion-transmitted virus among human immunodeficiency virus-infected subjects in northern ItalyA Lobbiani, L Sciariada, R Morales, et al.
HIV Medicine|July 2, 2008
Indicator disease-guided testing for HIV--the next step for Europe?B Gazzard, N Clumeck, A d'Arminio Monforte, et al.
Gastroenterology|October 1, 1982
Serum immunoglobulins in acute hepatitisF Caredda, A D'Arminio Monforte, E Rossi, et al.
Giornale Italiano Di Chemioterapia|January 1, 1991
[Opportunistic infections and tumors in AIDS]A Lazzarin, A Danise, A D'Arminio-Monforte, et al.
The Journal of Infectious Diseases|February 1, 1984
An outbreak of delta agent among a group of drug addicts and their close contactsF Caredda, E Rossi, A d'Arminio Monforte, et al.
Rays|January 1, 1994
Opportunistic infections of central nervous system in immunocompromised patientsM Moroni, C Gervasoni, P Coppin, et al.
Antiviral Therapy|May 7, 2003
Anti-HIV-1 intermittent drug intensification in HIV-1-infected patients naive for antiretroviralsS Rusconi, B Argenteri, M Galli, et al.
Lancet (London, England)|July 4, 1981
Non-A, non-B hepatitis in MilanF Caredda, A d'Arminio Monforte, E Rossi, et al.
Pageof 14